Growth Metrics

RemSleep Holdings (RMSL) Net Income towards Common Stockholders Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -18.72%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 13.91%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 98.96%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.60%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 89.28%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -30.10%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 RemSleep Holdings - - -7,636.00 -4.03%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -4.03%
Sep 30, 2025 -731.98%
Jun 30, 2025 -27.56%
Mar 31, 2025 66.15%
Dec 31, 2024 69.57%
Sep 30, 2024 -2.76%
Jun 30, 2024 -1.08%
Mar 31, 2024 -11.63%
Dec 31, 2023 -153.20%
Sep 30, 2023 13.37%
Jun 30, 2023 49.31%
Mar 31, 2023 28.47%
Dec 31, 2022 -163.86%
Sep 30, 2022 62.49%
Jun 30, 2022 81.37%
Mar 31, 2022 32.91%
Dec 31, 2021 76.34%
Sep 30, 2021 -206.53%
Jun 30, 2021 -6,186.82%
Mar 31, 2021 -72.37%
Dec 31, 2020 23.32%
Sep 30, 2020 -251.89%
Jun 30, 2020 101.65%
Mar 31, 2020 53.78%
Dec 31, 2019 -315.01%
Sep 30, 2019 77.89%
Jun 30, 2019 -662.89%
Mar 31, 2019 -264.99%
Dec 31, 2018 282.27%
Sep 30, 2018 -217.06%
Jun 30, 2018 -7.71%
Mar 31, 2018 6.07%
Dec 31, 2017 -31.16%
Sep 30, 2017 -45,563.07%
Jun 30, 2017 -8,741.98%
Mar 31, 2017 -557.28%
Dec 31, 2016 -1,170.33%
Sep 30, 2016 -4.78%
Jun 30, 2016 91.63%
Mar 31, 2016 23.13%
Dec 31, 2015 93.71%
Sep 30, 2015 -101.05%
Jun 30, 2015 -280.31%
Mar 31, 2015 -259.53%
Dec 31, 2014 1.23%
Sep 30, 2014 112.14%
Jun 30, 2014 102.70%
Mar 31, 2014 110.38%
Dec 31, 2013 17.84%
Sep 30, 2013 61.57%
Jun 30, 2013 -21.15%
Mar 31, 2013 -1,095.58%
Dec 31, 2012 -1,055.05%
Jun 30, 2012 -845.45%
Mar 31, 2012 9.48%
Dec 31, 2011 99.98%